Skip to main content
# Title Department Research Year
61 Bioassay-guided isolation and in Silico characterization of cytotoxic compounds from Hemimycale sp. Sponge targeting A549 lung cancer cells Department of Pharmaceutical Organic Chemistry 2024
62 Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study Department of Industrial Pharmacy 2024
63 Computational Design of Azine-Linked Hybrids of 2-Indolinone-Thiazolodine Scaffold as Novel and Promising Quorum Sensing Inhibitors Department of Medicinal Chemistry 2024
64 Spectral, XRD, morphological, DFT, and molecular modeling investigations of newly prepared isatin Schiff base complexes Department of Medicinal Chemistry 2024
65 Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
66 A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity Department of Pharmaceutics 2024
67 New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
68 Comparative study of Lepidium sativum orally administered seeds, hydrogel and atorvastatin on obesity of rats fed on a high fat diet Department of Industrial Pharmacy 2024
69 Curcumin-loaded gold nanoparticles with enhanced antibacterial efficacy and wound healing properties in diabetic rats Department of Pharmaceutics 2024
70 Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor Department of Pharmaceutical Analytical Chemistry 2023